Maze Therapeutics (MAZE) Cash & Equivalents (2024 - 2026)
Maze Therapeutics (MAZE) recorded Cash & Equivalents of $202.64 million in Q2 2026, down 23.4% from $264.54 million a year earlier but up 2.0% from the prior quarter.
Powered by 
Analysis
Maze Therapeutics (MAZE) Cash & Equivalents (2024 - 2026) Analysis & Trends
At the end of FY2025, Maze Therapeutics reported Cash & Equivalents of $189.25 million, down 3.8% from FY2024.
- Across earlier years, Cash & Equivalents came in at $196.81 million in FY2024.
- Quarterly Cash & Equivalents has ranged from $30.02 million in Q1 2024 to $316.77 million in Q3 2025 over the past five years.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 163.9% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $198.77 million (Q1 2026), $189.25 million (Q4 2025) and $316.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Maze Therapeutics | 1.48 Bn | 1.48 Bn | - | 202.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202.64 Mn |
| Mar 31, 2026 | 198.77 Mn |
| Dec 31, 2025 | 189.25 Mn |
| Sep 30, 2025 | 316.77 Mn |
| Jun 30, 2025 | 264.54 Mn |
| Mar 31, 2025 | 294.37 Mn |
| Dec 31, 2024 | 196.81 Mn |
| Sep 30, 2024 | 149.61 Mn |
| Jun 30, 2024 | 175.07 Mn |
| Mar 31, 2024 | 30.02 Mn |
API Access
Maze Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MAZE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MAZE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MAZE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();